Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 10, Issue 2, 2015, Pages 286-301

  Wang, Ming Chuan ^a   Chang, Ying Hua ^a   Wu, Chih Chieh ^a   Tyan, Yu Chang ^b,c,d   Chang, Hua Chien ^a   Goan, Yih Gang ^e   Lai, Wu Wei ^f   Cheng, Pin Nan ^f   Liao, Pao Chi ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ACTN4; CL1 0 and CL1 5 cell lines; non small cell lung cancers; siRNA

Indexed keywords

ALPHA ACTININ 4; ACTININ; ACTN4 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER PATIENT; CANCER TISSUE; CELL MOTILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL GROWTH; CELL MOTION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ACTININ; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84922247991     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000396     Document Type: Article

References (41)

1. D'Addario G, Fruh M, Reck M, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21 Suppl 5:v116-v119
2. Johnson DH. Management of small cell lung cancer: current state of the art. Chest 1999;116:525S-530S.
3. Ettinger DS. Overview and state of the art in the management of lung cancer. Oncology (Williston Park) 2004;18:3-9
4. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-458
5. Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol 2009;34:881-895
6. Volmer MW, Stühler K, Zapatka M, et al. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics 2005;5:2587-2601
7. Chu YW, Yang PC, Yang SC, et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997;17:353-360
8. Chiu KH, Chang YH, Wu YS, Lee SH, Liao PC. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J Proteome Res 2011;10:1110-1125
9. Chang YH, Lee SH, Liao IC, Huang SH, Cheng HC, Liao PC. Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics 2012;11:1320-1339
10. Chang YH, Lee SH, Chang HC, et al. Comparative secretome analyses using a hollow fiber culture system with label-free quantitative proteomics indicates the influence of PARK7 on cell proliferation and migration/invasion in lung adenocarcinoma. J Proteome Res 2012;11:5167-5185
11. Ebashi S, Ebashi F. A new protein factor promoting contraction of actomyosin. Nature 1964;203:645-646
12. Goto H, Wakui H, Komatsuda A, et al. Renal alpha-actinin-4: purification and puromycin aminonucleoside-binding property. Nephron Exp Nephrol 2003;93:e27-e35
13. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-930
14. Honda K, Yamada T, Endo R, et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 1998;140:1383-1393
15. Virel A, Backman L. Molecular evolution and structure of alpha-actinin. Mol Biol Evol 2004;21:1024-1031
16. Mejillano MR, Kojima S, Applewhite DA, Gertler FB, Svitkina TM, Borisy GG. Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 2004;118:363-373
17. Khurana S, George SP. The role of actin bundling proteins in the assembly of filopodia in epithelial cells. Cell Adh Migr 2011;5:409-420
18. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359-369
19. Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E Jr. The 7th lung cancer TNM classification and staging system: review of the changes and implications. World J Radiol 2012;4:128-134
20. Yilmaz M, Christofori G. Mechanisms of motility in metastasizing cells. Mol Cancer Res 2010;8:629-642
21. Tojkander S, Gateva G, Lappalainen P. Actin stress fibers-assembly, dynamics and biological roles. J Cell Sci 2012;125(Pt 8):1855-1864
22. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004;265:23-32
23. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004;16:590-596
24. Shao H, Wang JH, Pollak MR, Wells A. a-Actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One 2010;5:e13921
25. Yamamoto S, Tsuda H, Honda K, et al. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Histopathology 2012;60:1073-1083
26. Welton JL, Khanna S, Giles PJ, et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 2010;9:1324-1338
27. Choi DS, Lee JM, Park GW, et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 2007;6:4646-4655
28. Hegmans JP, Bard MP, Hemmes A, et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 2004;164:1807-1815
29. Gonzalez-Begne M, Lu B, Han X, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 2009;8:1304-1314
30. Yamada S, Yanamoto S, Yoshida H, et al. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2010;39:61-67
31. Pollard TD, Cooper JA. Actin, a central player in cell shape and movement. Science 2009;326:1208-1212
32. Hamill KJ, Hopkinson SB, Skalli O, Jones JC. Actinin-4 in keratinocytes regulates motility via an effect on lamellipodia stability and matrix adhesions. FASEB J 2013;27:546-556
33. Hayashida Y, Honda K, Idogawa M, et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res 2005;65:8836-8845
34. Araki N, Hatae T, Yamada T, Hirohashi S. Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages: analysis by fluorescence ratio imaging. J Cell Sci 2000;113(Pt 18):3329-3340
35. Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011;2011:842849
36. Paci M, Maramotti S, Bellesia E, et al. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009;64:92-97
37. Valadi H, Ekstrom K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-659
38. Aksenova V, Turoverova L, Khotin M, et al. Actin-binding protein alphaactinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB. Oncotarget 2013;4:362-372
39. Barbolina MV, Adley BP, Kelly DL, et al. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Lab Invest 2008;88:602-614
40. Kim YH, Kwon HJ, Kim DS. Matrix metalloproteinase 9 (MMP-9)-dependent processing of βig-h3 protein regulates cell migration, invasion, and adhesion. J Biol Chem 2012;287:38957-38969
41. Cox G, Jones JL, O'Byrne KJ. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res 2000;6:2349-2355